Brooks Laboratories Q4 Results
- BSE: 533543
- NSE: BROOKS
- ISIN: INE650L01011
- Sector: Major Drugs
BSE
66.25
2.68 (4.22%)
2.68 (4.22%)Volume6.84 K
Updated: Fri 11 Sep, 2026 | 15:28:48
NSE
66.382.53 (3.96%)
2.53 (3.96%)Volume1.02 L
Updated: Fri 11 Sep, 2026 | 15:29:23
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Brooks Laboratories Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 19.94 | 16.23 | 22.91% | 17.80 | -10.01% |
| Depreciation/ Amortization | 0.41 | 0.39 | 5.04% | 0.46 | 6.48% |
| Operating Income | 0.27 | 0.34 | -21.79% | -0.08 | -77.00% |
| Net Income | 1.52 | 5.50 | -72.30% | -9.61 | 0.00% |
| Net Income Before Taxes | 1.52 | 5.50 | -72.30% | -9.61 | 0.00% |
| Other Operating Expenses Total | 3.26 | 3.12 | 4.61% | 2.35 | 26.32% |
| Total Revenue | 20.21 | 16.57 | 21.99% | 17.72 | -13.33% |
| Selling/ General/ Admin Expenses Total | 3.85 | 3.72 | 3.60% | 2.28 | 13.83% |
| Diluted Normalized EPS | 0.52 | 1.87 | -72.37% | -3.75 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.